BC Week In Review | Jan 27, 2014
Company News

Innovative Diagnostic Laboratory LLP sales and marketing update

Innovative Diagnostic launched the ColonSentry blood test in the U.S. to assess a patient's risk for colorectal cancer. The company launched the blood-based test for seven mRNA biomarkers of colorectal cancer on a limited basis...
BioCentury | Oct 7, 2013
Finance

3Q Stock Wrap-Up: Make it a double

For the second time this year, all market cap segments closed the quarter in the black. Large caps valued at $5 billion and above gained ground for the fifth consecutive quarter. They added 12%, and...
BC Week In Review | Sep 2, 2013
Company News

GeneNews diagnostic news

GeneNews said it expects to reduce its number of employees by about 60% by Nov. 30. The company declined to disclose exact numbers of the reduction. The company said the move will extend its cash...
BC Week In Review | Jul 15, 2013
Company News

GeneNews, Health Diagnostic Laboratory deal

GeneNews formed a JV with Health Diagnostic and an undisclosed sales company to establish clinical laboratory, Innovative Diagnostic Laboratory LLP (Richmond, Va.). Innovative Diagnostic, which expects to become CLIA certified and begin operations this quarter,...
BC Week In Review | Oct 1, 2012
Company News

GeneNews, Shanghai Biochip deal

The companies will establish the Sentinel Center for Personalized Medicine in Shanghai that would co-develop and commercialize products based on GeneNews' Sentinel Principle technology. The technology identifies disease biomarkers from blood. Shanghai Biochip also received...
BC Week In Review | Apr 16, 2012
Company News

Enzo, GeneNews sales and marketing update

Enzo launched GeneNews' ColonSentry blood test in the New York metropolitan area to assess a patient's risk for colorectal cancer. Enzo has exclusive marketing rights to the blood-based test for seven mRNA biomarkers of colorectal...
BC Week In Review | Mar 5, 2012
Clinical News

ColonSentry regulatory update

Marketing partner Enzo Biochem Inc. (NYSE:ENZ, Farmingdale, N.Y.) said the New York State Department of Health approved GeneNews' ColonSentry blood test to assess a patient's risk for colorectal cancer. Enzo plans to launch the blood-based...
BC Week In Review | Feb 13, 2012
Company News

GeneNews, Shanghai Biochip Co. Ltd. deal

The companies signed a memorandum of understanding (MOU) to jointly establish and manage the Sentinel Center for Personalized Medicine in China that would co-develop and commercialize products based on GeneNews' Sentinel Principle technology. The technology...
BC Week In Review | Sep 6, 2010
Clinical News

ColonSentry diagnostic data

A study evaluating blood samples from 377 colorectal cancer patients and 409 healthy controls showed that GeneNews' ColonSentry blood test had 76% sensitivity and 67% specificity for detecting colorectal cancer. Additionally, the test had 69%...
BC Week In Review | Jul 5, 2010
Company News

GeneDiagnostics Inc., GeneNews sales and marketing update

The companies completed their previously announced deal granting GeneDiagnostics non-exclusive rights to market GeneNews' ColonSentry test for colorectal cancer in Shanghai and the provinces of Zhejiang and Jiangsu. GeneNews markets ColonSentry, which measures mRNA expression...
Items per page:
1 - 10 of 16